NDSIB
EW icon

North Dakota State Investment Board’s Edwards Lifesciences EW Stock Holding History

North Dakota State Investment Board’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
17,114
+441
+3% +$36.9K 0.06% 256
2026
Q1 		$1.34M Sell
16,673
-3,055
-15% -$252K 0.06% 258
2025
Q4 		$1.68M Buy
+19,728
New +$1.62M 0.06% 243

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

North Dakota State Investment Board's EW Position: Q2 2026 in Review

North Dakota State Investment Board increased its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, buying an estimated $36.9K and bringing the position to 17,114 shares worth $1.55M. The position accounts for 0.06% of the portfolio, ranked #256.

North Dakota State Investment Board first reported a position in EW in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.68M in Q4 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • North Dakota State Investment Board held 17,114 shares of Edwards Lifesciences worth $1.55M as of Q2 2026.
  • North Dakota State Investment Board bought 441 Edwards Lifesciences shares in Q2 2026, an estimated $36.9K.
  • Edwards Lifesciences made up 0.06% of North Dakota State Investment Board's portfolio in Q2 2026, its #256 holding.
  • North Dakota State Investment Board first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Edwards Lifesciences position peaked at $1.68M in Q4 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.